Michele Vespignani

VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

Gino Santini, Luigi Salvagno, Pietro Leoni et al. · Journal of Clinical Oncology · 1998 · 207 citations

Medicine, Hematology, Oncology +14

Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

Corrado Girmenia, Gian María Rossolini, Alfonso Piciocchi et al. · Bone Marrow Transplantation · 2014 · 188 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions

Gianpietro Semenzato, Franco Pandolfi, Teodoro Chisesi et al. · Cancer · 1987 · 178 citations

Medicine, Hematology, Pathology +16

MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.

M.R. Sertoli, Gino Santini, Teodoro Chisesi et al. · Journal of Clinical Oncology · 1994 · 39 citations

Medicine, Oncology, Pharmacology +11

Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups

Renato Bassan, Enrico Pogliani, Paolo Casula et al. · The Hematology Journal · 2001 · 33 citations

Medicine, Hematology, Oncology +17